Evaluation of the Correlation Between Herpes Simplex Virus-2 Infection and Adverse Birth Outcomes Among Rural Pregnant Women In Mysore District, India
Date
Authors
Contributor
Advisor
Department
Instructor
Depositor
Speaker
Researcher
Consultant
Interviewer
Narrator
Transcriber
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
Project Title: Evaluation of the correlation between herpes simplex virus-2 infection and adverse birth outcomes among rural pregnant women in Mysore district, India.
Background: Herpes simplex virus type 2 (HSV-2) is one of the most common sexually transmitted infections worldwide and the main cause of genital ulcers. Although HSV-2 prevalence varies among countries and population, it is more prevalent in developing countries rather than developed countries. HSV-2 can be transmitted sexually, when ulcers or lesions are present, or when skin is broken. HSV-2 is a lifelong asymptomatic infection, however, antivirals can be used to suppress the virus shedding. People with HSV-2 infection are at increased risk for HIV acquisition and transmission, thus the increase in risk of perinatal transmission. Infants exposed to HSV-2 during vaginal delivery can have severe disabilities and malformations. Objective: The objective of this project is to evaluate the prevalence of HSV-2 among pregnant women during childbirth and the correlation HSV-2 has with adverse birth outcomes.
Materials and Methods: Blood samples were collected from pregnant women from Mysore subdistrict, India, in a previously completed project that Public Health Research Institute of India (PHRII) conducted in 2011-2014 called Saving Children Improving Lives (SCIL). All women were administered informed consent prior to the blood draw. Pregnancy outcomes were documented immediately after birth, 3 months and 6 months after delivery. From the SCIL study, 306 random serum samples were analyzed based on their adverse birth outcomes. HerpeSelect 2 ELISA IgG kit (Focus Diagnostics, USA) was used to test the serum samples for HSV-2 specific antibodies. An HSV-2 IgG/IgM Rapid Test kit was also used to retest the ELISA positive serum samples.
Results: Out of the 306 serum samples tested using ELISA there were 17 (5.5%) positive samples with nine (2.9%) high positive (> 3.5 Index Value) and eight (2.6%) low positive (1.10 – 3.5 Index Value), two equivocal and the remaining serum samples were negative. The HSV-2 IgG/IgM Rapid test detected nine samples positive for HSV-2 IgG antibodies; eight from the high positive and one from the low positive serum samples.
Conclusion: Of the 306 serum samples tested from women during childbirth, 5.6% were positive for HSV-2. Data analysis to evaluate the correlation between positive serum samples and the birth outcomes is ongoing.